Cooperative Agreement U01PS005282

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $702,000 to optimize the implementation of long-acting injectable PrEP (LAI-PrEP) in the United States. The key objectives are to: (1) identify barriers and facilitators to LAI-PrEP implementation, (2) determine optimal implementation strategies in partnership with stakeholders, and (3) pilot an implementation strategy...

This federal Project Grant award of $1,260,957 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to identify preferences and care components to optimize the delivery of long-acting injectable (LAI) PrEP for sexual minority men (SMM) who use methamphetamine in the U.S. The study has two key objectives: 1) conduct qualitative interviews with SMM who use methamphetamine and healthcare providers to develop a discrete choice...

This Project Grant award from the National Institute of Mental Health (NIMH) under CFDA 93.242 - Mental Health Research Grants supports a research study to enhance access to pre-exposure prophylaxis (PrEP) for Black and Latinx sexual minority men in the Bronx, New York. The $252,000 award to Albert Einstein College of Medicine aims to: 1) co-design and validate a system dynamics model identifying factors influencing PrEP engagement for this population, and 2) use the model to determine the...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $1,576,238 to characterize, assess, and protocolize implementation strategies used by community-based organizations to improve the reach of pre-exposure prophylaxis (PrEP) and mental health/substance use (MH/SU) treatments to Latino men who have sex with men (LMSM) in Ending the HIV Epidemic (EHE)...

This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $616,742.00 to the New York Blood Center, Inc. to conduct research on the impact of geographic mobility on pre-exposure prophylaxis (PrEP) and HIV care outcomes among Latino gay, bisexual, and other men who have sex with men (GBMSM) in New York City. The study aims to characterize patterns of geographic mobility and determine how past-year...

This $1,260,020 federal Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports the implementation and evaluation of an evidence-based trauma treatment integrated with community-led PrEP navigation services for transgender and gender diverse (TGD) individuals affected by violence and HIV in Los Angeles County. The 3-year pilot study will assess the acceptability, feasibility,...

This $2,127,639 federal Project Grant awarded by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will fund a multi-level integrated strategy to optimize PrEP adherence and accelerate implementation at scale for Black men who have sex with men (MSM). The strategy combines two evidence-based interventions: 1) The "Many Men, Many Voices" (3MV) group-level behavioral intervention to increase healthcare seeking behaviors,...

This federal Project Grant award of $146,922 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research to understand patient-level implementation determinants related to long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young men who have sex with men living in rural areas. The award, with a project period from December 2024 to March 2025, is being provided to The Medical College of Wisconsin, Inc., a...

This K23 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a $364,832 implementation science study to deliver and evaluate an enhanced care intervention, HIV Prevention Plus Care (HP+ Care), for young men who have sex with men (YMSM) starting pre-exposure prophylaxis (PrEP) at two clinics. The HP+ Care intervention will include motivational interviewing and personalized health education to promote...

This federal Project Grant award, funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), provides $186,840 to the University of Chicago to develop, pilot, and evaluate a multilevel intervention that combines a refined media campaign and peer-based strategy, informed by social network analysis. The project aims to promote the use of pre-exposure prophylaxis (PrEP) among young Latino sexual minority men, a population...